Drug class
Agents to Treat Chronic Idiopathic Constipation/IBS-C/OIC
The phrase "Agents to Treat Chronic Idiopathic Constipation/IBS-C/OIC" represents a composite clinical and formulary categorization rather than a single pharmacologic drug class. Read more about Agents to Treat Chronic Idiopathic Constipation/IBS-C/OIC
34 drugs in this class 33 manufacturers
Drugs in Agents to Treat Chronic Idiopathic Constipation/IBS-C/OIC
PRUCALOPRIDE (prucalopride succinate)
PRUCALOPRIDE (prucalopride succinate)
PRUCALOPRIDE (prucalopride succinate)
PRUCALOPRIDE (prucalopride succinate)
PRUCALOPRIDE (prucalopride succinate)
PRUCALOPRIDE (prucalopride succinate)
PRUCALOPRIDE (prucalopride succinate)
PRUCALOPRIDE (prucalopride succinate)
The phrase "Agents to Treat Chronic Idiopathic Constipation/IBS-C/OIC" represents a composite clinical and formulary categorization rather than a single pharmacologic drug class.
It encompasses several distinct mechanistic classes—most notably intestinal secretagogues like guanylate cyclase-C agonists and chloride channel activators, 5-HT4 receptor agonists, and peripherally acting mu-opioid receptor antagonists.
Functioning to increase intestinal fluid secretion, accelerate gastrointestinal transit, or reverse opioid-induced bowel dysfunction, these medications provide targeted symptom management beyond conventional laxatives.
They are indicated for adults with chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C), and opioid-induced constipation (OIC).
-
nih.gov
The phrase "Agents to Treat Chronic Idiopathic Constipation/IBS-C/OIC" represents a composite clinical and formulary categorization rather than a single pharmacologic drug class It encompasses several distinct mechanistic classes—most notably intestinal secretagogues like guanylate cyclase-C agonists and chloride channel activators, 5-HT4 receptor agonists, and peripherally acting mu-opioid receptor antagonists Functioning to increase intestinal fluid secretion, accelerate gastrointestinal trans...
-
nih.gov
The phrase "Agents to Treat Chronic Idiopathic Constipation/IBS-C/OIC" represents a composite clinical and formulary categorization rather than a single pharmacologic drug class
-
iffgd.org
The phrase "Agents to Treat Chronic Idiopathic Constipation/IBS-C/OIC" represents a composite clinical and formulary categorization rather than a single pharmacologic drug class They are indicated for adults with chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C), and opioid-induced constipation (OIC)
-
youandconstipation.org
It encompasses several distinct mechanistic classes—most notably intestinal secretagogues like guanylate cyclase-C agonists and chloride channel activators, 5-HT4 receptor agonists, and peripherally acting mu-opioid receptor antagonists Functioning to increase intestinal fluid secretion, accelerate gastrointestinal transit, or reverse opioid-induced bowel dysfunction, these medications provide targeted symptom management beyond conventional laxatives
-
ahdbonline.com
It encompasses several distinct mechanistic classes—most notably intestinal secretagogues like guanylate cyclase-C agonists and chloride channel activators, 5-HT4 receptor agonists, and peripherally acting mu-opioid receptor antagonists They are indicated for adults with chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C), and opioid-induced constipation (OIC)
-
pharmacytimes.com
Functioning to increase intestinal fluid secretion, accelerate gastrointestinal transit, or reverse opioid-induced bowel dysfunction, these medications provide targeted symptom management beyond conventional laxatives
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.